BIODESIX INC (BDSX) Stock Income Statement
NASDAQ:BDSX - Nasdaq - US09075X1081 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 65.56M | 49.09M | 38.21M | 54.51M | 45.56M | |||
| Cost Of Goods | 14.61M | 13.01M | 14.15M | 30.52M | 22.00M | |||
| Gross Profit | 50.96M | 36.08M | 24.06M | 23.99M | 23.56M | |||
| Operating Expenses | 85.52M | 77.38M | 74.57M | 64.93M | 46.49M | |||
| Research and Development | 9.03M | 9.99M | 13.10M | 12.79M | 10.82M | |||
| Selling, General, and Administrative Expenses | 76.48M | 64.52M | 58.46M | 47.96M | 32.33M | |||
| Operating Income | -34.56M | -41.30M | -50.51M | -40.94M | -22.93M | |||
| Interest Income/Expense | -8.84M | -9.54M | -8.07M | -4.51M | -7.59M | |||
| Other Income/Expense | -17.00K | -1.27M | 190.00K | -10.00K | -830.00K | |||
| Non Recurring Items | -407.00K | -44.00K | -7.06M | 2.30M | -820.00K | |||
| Income Before Taxes | -43.82M | -52.15M | -65.45M | -43.16M | -31.35M | |||
| Net Income | -43.82M | -52.15M | -65.45M | -43.16M | -31.35M | |||
| EBITDA | -29.26M | -37.97M | -46.91M | -37.76M | -20.03M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.39 | -0.64 | -1.55 | -1.58 | -1.18 | |||
| Non GAAP EPS | -0.39 | -0.65 | -1.59 | -1.54 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 77.72% | 73.50% | 62.97% | 44.01% | 51.71% | |||
| Profit Margin | -66.84% | -106.23% | -171.29% | -79.18% | -68.81% | |||
| Operating Profit Margin | -52.71% | -84.13% | -132.19% | -75.11% | -50.33% | |||
All data in USD